0001209191-22-061091.txt : 20221213
0001209191-22-061091.hdr.sgml : 20221213
20221213211816
ACCESSION NUMBER: 0001209191-22-061091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221209
FILED AS OF DATE: 20221213
DATE AS OF CHANGE: 20221213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALLEN SIMON
CENTRAL INDEX KEY: 0001606829
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40388
FILM NUMBER: 221461032
MAIL ADDRESS:
STREET 1: C/O AMBRX, INC.
STREET 2: 10975 N. TORREY PINES RD.
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001815974
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851170950
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1415 RANCH ROAD 629 SOUTH, SUITE 201
CITY: LAKEWAY
STATE: TX
ZIP: 78734
BUSINESS PHONE: 737 203 5270
MAIL ADDRESS:
STREET 1: 1415 RANCH ROAD 629 SOUTH, SUITE 201
CITY: LAKEWAY
STATE: TX
ZIP: 78734
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-09
0
0001815974
Anebulo Pharmaceuticals, Inc.
ANEB
0001606829
ALLEN SIMON
C/O ANEBULO PHARMACEUTICALS, INC.
1415 RANCH ROAD 620 SOUTH, SUITE 201
LAKEWAY
TX
78734
1
1
0
0
Chief Executive Officer
Stock Option (right to buy)
3.37
2022-12-09
4
A
0
70246
0.00
A
2032-12-08
Common Stock
70246
70246
D
The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter first occurring after December 9, 2022.
/s/ Simon Allen
2022-12-13